Customer Spotlight: Catalent on CLD
Find out how Catalent Biologics is able to select significantly higher expressing clonal cell lines with the Opto CLD workflow.
Download FileRelated Resources
View All ResourcesProduct Tour: The Opto™ CLD Workflow
Antibody expert, Anupam Singhal, PhD, does a 10-minute walkthrough of how the Opto™ CLD workflow makes it possible to produce superior cell lines, with >99% monoclonality assurance, in a matter of days.
Fireside Chat: Every Day Matters – Optimizing COVID-19 Therapies for Manufacturing
Dr. James Rothman, Nobel Laureate hosts an in-depth discussion with distinguished guests, Dr. Jennitte Stevens from Amgen, Dr. Gregory Bleck from Catalent-Biologics, and Dr. Trent Munro from the University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2.
Cell Line Development Webinar: Digital Week 2019
Learn about improved and expedited cell line development on the Beacon platform from Biogen’s Rachel Ferguson.